Role of c-kit/Kit ligand signaling in regulating vasculogenesis

Thrombosis and Haemostasis

Volumn 90, Issue 4, 2003, Pages 570-576

  Heissig, Beate ^a   Werb, Zena ^b   Rafii, Shahin ^c   Hattori, Koichi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Department of Obstetrics Gynecology   (United States)

Author keywords

Endothelial progenitor cells; Matrix metalloproteinase 9; Stem cells; Tyrosine kinase receptor; Vasculogenesis

Indexed keywords

2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; CHEMOKINE; CYTOKINE; FLUOROURACIL; GELATINASE B; IMATINIB; PLACENTAL GROWTH FACTOR; PROTEIN TYROSINE KINASE INHIBITOR; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN INHIBITOR; VATALANIB;

ADOPTIVE IMMUNOTHERAPY; ANGIOGENESIS; ATHEROSCLEROSIS; BONE MARROW SUPPRESSION; CANCER THERAPY; CIRCULATION; DRUG POTENTIATION; DRUG TARGETING; ENDOTHELIUM CELL; GROWTH REGULATION; HEMATOPOIETIC STEM CELL; HUMAN; NONHUMAN; PANCREAS ISLET CELL CARCINOMA; PREMATURITY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; STEM CELL; STEM CELL MOBILIZATION; TUMOR GROWTH; TUMOR VASCULARIZATION; VASCULAR DISEASE; WOUND HEALING;

EID: 0142092593     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-03-0188     Document Type: Review

References (59)

1. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9(6): 653-60.
2. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275(5302): 964-7.
3. Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5(4): 434-8.
4. Tateishi-Yuyama E, Matsubara H, Murohara T, et al.. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomised controlled trial. Lancet 2002; 360(9331): 427-35.
5. Shimizu K, Sugiyama S, Aikawa M, et al.. Host bone-marrow cells are a source of donor intimal smooth- muscle-like cells in murine aortic transplant arteriopathy. Nat Med 2001; 7(6): 738-41.
6. Lyden D, Hattori K, Dias S, et al.. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001; 7(11): 1194-201.
7. Gussoni E, Soneoka Y, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999; 401(6751): 390-4.
8. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85(3): 221-8.
9. Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109(5): 625-37.
10. Lin Y, Weisdorf DJ, Solovey A, et al.. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105(1): 71-7.
11. Rafii S, Heissig B, Hattori K. Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors. Gene Ther 2002; 9(10): 631-41.
12. Rafii S, Lyden D, Benezra R, et al.. Vascular and haematopoietic stem cells: Novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2002; 2(11): 826-35.
13. Rehman J, Li J, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003; 107(8): 1164-9.
14. Kessinger A, Armitage JO, Landmark JD, et al.. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 1988; 71(3): 723-7.
15. Abkowitz JL, Robinson AE, Kale S, et al.. The mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure. Blood 2003; 24: 24.
16. Coussens LM, Tinkle CL, Hanahan D, Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000; 103(3): 481-90.
17. Vajkoczy P, Blum S, Lamparter M, et al. Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 2003; 197(12): 1755-65.
18. Leung DW, Cachianes G, Kuang WJ, et al.. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246(4935): 1306-9.
19. Flamme I, Breier G, Risau W. Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo. Dev Biol 1995; 169(2): 699-712.
20. Fong FH, Rossant J, Gertsenstein M, et al.. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995; 376(6535): 66-70.
21. Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380(6573): 439-42.
22. Pepper MS, Mandriota SJ. Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells. Exp Cell Res 1998; 241(2): 414-25.
23. Hattori K, Dias S, Heissig B, et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 2001; 193(9): 1005-14.
24. Kabrun N, Buhring HJ, Choi K, et al.. Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development 1997; 124(10): 2039-48.
25. Hattori K, Heissig B, Wu Y, et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med 2002; 8(8): 841-9.
26. Shintani S, Murohara T, Ikeda H, et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001; 103(23): 2776-9.
27. Wright DE, Cheshier SH, Wagers AJ, et al.. Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle. Blood 2001; 97(8): 2278-85.
28. To LB, Haylock DN, Simmons PJ, et al.. The biology and clinical uses of blood stem cells. Blood 1997; 89(7): 2233-58.
29. Hattori K, Heissig B, Rafii S. The regulation of hematopoietic stem cell and progenitor mobilization by chemokine SDF-1. Leuk Lymphoma 2003; 44(4): 575-82.
30. Gupta SK, Lysko PG, Pillarisetti K, et al.. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J Biol Chem 1998; 273(7): 4287-7.
31. Volin MV, Joseph L, Shockley MS, et al.. Chemokine receptor CXCR4 expression in endothelium. Biochem Biophys Res Commun 1998; 242(1): 46-53.
32. Feil C, Augustin HG. Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines. Biochem Biophys Res Commun 1998; 247(1): 38-45.
33. Tachibana K, Hirota S, Iizasa H, et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998; 393(6685): 591-4.
34. Hattori K, Heissig B, Tashiro K, et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001; 97(11): 3354-3360.
35. Petit I, Szyper-Kravitz M, Nagler A, et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002; 3(7): 687-94.
36. Fibbe WE, Pruijt JF, Van Kooyk Y, et al.. The role of metalloproteinases and adhesion molecules in interleukin-8-induced stem-cell mobilization. Semin Hematol 2000; 37(1 Suppl 2): 19-24.
37. Natori T, Sata M, Washida M, et al.. G-CSF stimulates angiogenesis and promotes tumor growth: Potential contribution of bone marrow-derived endothelial progenitor cells. Biochem Biophys Res Commun 2002; 297(4): 1058-61.
38. Thomas J, Liu F, Link DC. Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor. Curr Opin Hematol 2002; 9(3): 183-9.
39. Ribatti D, Presta M, Vacca A, et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 1999; 93(8): 2627-36.
40. Heeschen C, Aicher A, Lehmann R, et al. Erythropoietin is a potent physiological stimulus for endothelial progenitor cell mobilization. Blood 2003; 17: 17.
41. Brizzi MF, Battaglia E, Montrucchio G, et al. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. Circ Res 1999; 84(7): 785-96.
42. Aicher A, Brenner W, Zuhayra M, et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003;107(16): 2134-9.
43. Yamaguchi J, Kusano KF, Masuo O, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003; 107(9): 1322-8.
44. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410(6829): 701-5.
45. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7(4): 430-6.
46. Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8(4): 403-9.
47. Carmeliet P, Moons L, Luttun A, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 7(5): 575-83.
48. Ichiyama K, Yokoyama-Kumakura S, Tanaka Y, et al.. A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity. Proc Natl Acad Sci U S A 2003; 100(7): 4185-90.
49. Bergers G, Brekken R, McMahon G, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2(10): 737-44.
50. McQuibban GA, Butler GS, Gong JH, et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 2001; 276(47): 43503-8.
51. Ito A, Mukaiyama A, Itoh Y, Nagase H, et al. Degradation of interleukin 1beta by matrix metalloproteinases. J Biol Chem 1996; 271(25): 14657-60.
52. Heissig B, Hattori K, Friedrich M, et al. Angiogenesis: Vascular remodeling of the extracellular matrix involves metalloproteinases. Curr Opin Hematol 2003; 10(2): 136-41.
53. Boesiger J, Tsai M, Maurer M, et al. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J Exp Med 1998; 188(6): 1135-45.
54. Zhang W, Stoica G, Tasca SI, et al.. Modulation of tumor angiogenesis by stem cell factor. Cancer Res 2000; 60(23): 6757-62.
55. Turner AM, Zsebo KM, Martin F, et al.. Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 1992; 80(2): 374-81.
56. Demetri GD, Von Mehren M, Blanke CD, et al.. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347(7): 472-80.
57. Bergers G, Song S, Meyer-Morse N, et al.. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 2003; 111(9): 1287-95.
58. Davidoff AM, Ng CY, Brown P, et al.. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin Cancer Res 2001; 7(9): 2870-9.
59. De Palma M, Venneri MA, Roca C, et al.. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med 2003; 9(6): 789-95.